DOI: 10.1111/j.1538-7836.2004.00744.x. Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug

Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug

10.1111/j.1538-7836.2004.00744.x

Crossref journal-article

Elsevier BV

Journal of Thrombosis and Haemostasis (78)

Bibliography

Curtis, B. R., Divgi, A., Garritty, M., & Aster, R. H. (2004). Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug. Journal of Thrombosis and Haemostasis, 2(6), 985â992.

Authors 4

B.R. Curtis (first)
A. Divgi (additional)
M. Garritty (additional)
R.H. Aster (additional)

References 38 Referenced 69

10.1172/JCI119307 / J Clin Invest / Platelet GPIIb/IIIa antagonists: the first anti‐integrin receptor therapeutics by Coller (1997)
10.1161/01.CIR.97.17.1680 / Circulation / Pharmaco‐dynamic profile of short‐term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GPIIb/IIIa receptor blockade by Mascelli (1998)
10.1056/NEJM199706123362401 / N Engl J Med / Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization (1997)
10.1016/S0140-6736(96)10452-9 / Lancet / Randomized placebo‐controlled trial of abciximab before and during coronary intervention in refractory unstable angina. The CAPTURE study (1997)
10.1056/NEJM199907293410503 / N Engl J Med / Complimentary clinical benefits of coronary‐artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors by Lincoff (1999)
10.1053/hj.1999.v138.99236 / Am Heart J / Readministration of abciximab: interim report of the ReoPro readministration registry by Tcheng (1999)
10.1016/S0735-1097(98)00252-6 / J Am Coll Cardiol / Occurrence and clinical significance of thrombocytopenia of a population of high‐risk percutaneous coronary revascularization by Berkowitz (1998)
10.1002/(SICI)1096-8652(199907)61:3<205::AID-AJH8>3.0.CO;2-9 / Am J Hematol / Acute profound thrombocytopenia following C7E3 Fab (abciximab) therapy: case reports, review of the literature, and implications for therapy by Jubelirar (1999)
10.1067/mhj.2000.106615 / Am Heart J / Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade by Kereiakes (2000)
10.1016/S0002-8703(98)70243-1 / Am Heart J / Glycoprotein IIb/IIIa antagonists. Potential induction and detection of drug‐dependent antiplatelet antibodies by Cines (1998)
10.1016/S0002-9149(99)00768-7 / Am J Cardiol / Effect of abciximab readministration in coronary intervention by Madan (2000)
10.1182/blood.V92.9.3240 / Blood / Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (αIIb/β3) inhibitors by Peter (1998)
10.1016/S0002-9149(99)00370-7 / Am J Cardiol / Platelet activation as a potential mechanism of GPIIb/IIIa inhibitor‐induced thrombocytopenia by Peter (1999)
10.1182/blood.V99.6.2054 / Blood / Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab‐coated platelets by Curtis (2002)
10.1161/01.CIR.97.12.1214 / Circulation / Delayed profound thrombocytopenia after c7E3 Fab (abciximab) therapy by Jenkins (1998)
10.1002/ccd.1108 / Cath Cardiovasc Interv / Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy by Reddy (2001)
10.1080/146288401753514515 / J Cardiovasc Interv / Delayed thrombocytopenia following abciximab therapy by Kaluski (2001)
10.1177/107424840200700i103 / J Cardiovasc Pharmacol Therapeut / Delayed profound thrombocytopenia presenting seven days after use of abciximab (ReoPro) by Sharma (2002)
10.1111/j.1365-2141.1994.tb04758.x / Br J Haematol / Incidence of autoantibodies to GPIIb/IIIa in chronic autoimmune thrombocytopenic purpura may be overestimated by the MAIPA by Hewitt (1994)
10.1161/01.CIR.89.2.596 / Circulation / Randomized trial of GPIIb/IIIa platelet receptor blocker in refractory unstable angina by Simoons (1994)
10.1016/0161-5890(95)00085-2 / Mol Immunol / The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions by Knight (1995)
{'key': '10.1111/j.1538-7836.2004.00744.x_bb0115', 'first-page': '2', 'article-title': 'Drug‐induced immune thrombocytopenia. An overview of pathogenesis', 'volume': '36', 'author': 'Aster', 'year': '1999', 'journal-title': 'Sem Hematol'} / Sem Hematol / Drug‐induced immune thrombocytopenia. An overview of pathogenesis by Aster (1999)
{'key': '10.1111/j.1538-7836.2004.00744.x_bb0120', 'series-title': 'Platelets.', 'first-page': '593', 'article-title': 'Drug‐induced thrombocytopenia', 'author': 'Aster', 'year': '2002'} / Platelets. / Drug‐induced thrombocytopenia by Aster (2002)
10.1182/blood.V84.1.176.176 / Blood / Antibodies associated with sulfonamide‐induced immune thrombocytopenia react preferentially with calcium‐dependent epitopes on the glycoprotein IIb/IIIa complex by Curtis (1994)
10.1056/NEJM200006153422402 / N Engl J Med / Thrombotic thrombocytopenic purpura associated with clopidogrel by Bennett (2000)
10.7326/0003-4819-136-3-200202050-00009 / Ann Intern Med / Delayed‐onset heparin‐induced thrombocytopenia by Rice (2002)
10.1056/NEJM200303133481120 / N Engl J Med / Delayed onset heparin‐induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin by Warkentin (2003)
10.1172/JCI116987 / J Clin Invest / Antibodies from patients with heparin‐induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells by Visentin (1994)
10.1016/S0022-2143(96)80009-6 / J Lab Clin Med / Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: PF4 complexes by Visentin (1996)
10.1023/A:1018708419564 / J Thromb Thrombolysis / Heparin‐induced thrombocytopenia and its treatment by Warkentin (2000)
10.1111/j.1365-2141.1994.tb08333.x / Br J Haematol / A new type of pseudo‐thrombocytopenia: EDTA‐mediated agglutination of platelets bearing Fab fragments of a chimeric antibody by Christopolous (1987)
10.1016/S0735-1097(00)00688-4 / J Am Coll Cardiol / Occurrence and clinical significance of pseudo‐thrombocytopenia during abciximab therapy by Sane (2000)
{'issue': 'Suppl. 1', 'key': '10.1111/j.1538-7836.2004.00744.x_bb0170', 'first-page': '222a', 'article-title': 'Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetics: distinct binding profile for roxifiban and its implications', 'volume': '94', 'author': 'Mousa', 'year': '1999', 'journal-title': 'Blood'} / Blood / Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetics: distinct binding profile for roxifiban and its implications by Mousa (1999)
10.1097/00001721-199304050-00009 / Blood Coag Fibrinol / Flow cytometric observations on thein vivouse of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb/IIIa by Christopoulos (1993)
10.1159/000460705 / Vox Sang / Anti‐gamma globulin factors in human sera revealed by enzymatic splitting of anti‐Rh antibodies by Osterland (1963)
10.1172/JCI112027 / J Clin Invest / Anti‐Fab antibodies in humans: predominance of minor immunoglobulin G subclasses in rheumatoid arthritis by Persselin (1985)
{'key': '10.1111/j.1538-7836.2004.00744.x_bb0190', 'first-page': '6851', 'article-title': 'Serological analysis of human anti‐human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33', 'volume': '61', 'author': 'Ritter', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Serological analysis of human anti‐human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33 by Ritter (2001)
10.1111/j.1365-2249.1994.tb06598.x / Clin Exp Immunol / Platelet surface IgG in patients receiving infusions of Fab chimeric monoclonal antibody to glycoprotein IIb/IIIa by Christopolous (1994)

Dates

Type	When
Created	20 years, 9 months ago (Nov. 15, 2004, 1:25 p.m.)
Deposited	2 years, 7 months ago (Jan. 15, 2023, 11:43 p.m.)
Indexed	1 week, 2 days ago (Aug. 29, 2025, 6:13 a.m.)
Issued	21 years, 3 months ago (June 1, 2004)
Published	21 years, 3 months ago (June 1, 2004)
Published Print	21 years, 3 months ago (June 1, 2004)

Funders 0

None

BibTeX

@article{Curtis_2004, title={Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug}, volume={2}, ISSN={1538-7836}, url={http://dx.doi.org/10.1111/j.1538-7836.2004.00744.x}, DOI={10.1111/j.1538-7836.2004.00744.x}, number={6}, journal={Journal of Thrombosis and Haemostasis}, publisher={Elsevier BV}, author={Curtis, B.R. and Divgi, A. and Garritty, M. and Aster, R.H.}, year={2004}, month=jun, pages={985–992} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        29
      ]
    ],
    "date-time": "2025-08-29T10:13:48Z",
    "timestamp": 1756462428312
  },
  "reference-count": 38,
  "publisher": "Elsevier BV",
  "issue": "6",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2004,
            6,
            1
          ]
        ],
        "date-time": "2004-06-01T00:00:00Z",
        "timestamp": 1086048000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    },
    {
      "start": {
        "date-parts": [
          [
            2022,
            12,
            12
          ]
        ],
        "date-time": "2022-12-12T00:00:00Z",
        "timestamp": 1670803200000
      },
      "content-version": "vor",
      "delay-in-days": 6768,
      "URL": "http://www.elsevier.com/open-access/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [
      "elsevier.com",
      "sciencedirect.com"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  },
  "DOI": "10.1111/j.1538-7836.2004.00744.x",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        11,
        15
      ]
    ],
    "date-time": "2004-11-15T18:25:31Z",
    "timestamp": 1100543131000
  },
  "page": "985-992",
  "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
  "source": "Crossref",
  "is-referenced-by-count": 69,
  "title": "Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug",
  "prefix": "10.1016",
  "volume": "2",
  "author": [
    {
      "given": "B.R.",
      "family": "Curtis",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "A.",
      "family": "Divgi",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "M.",
      "family": "Garritty",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "R.H.",
      "family": "Aster",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0010",
      "doi-asserted-by": "crossref",
      "first-page": "1467",
      "DOI": "10.1172/JCI119307",
      "article-title": "Platelet GPIIb/IIIa antagonists: the first anti\u2010integrin receptor therapeutics",
      "volume": "99",
      "author": "Coller",
      "year": "1997",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0015",
      "doi-asserted-by": "crossref",
      "first-page": "1680",
      "DOI": "10.1161/01.CIR.97.17.1680",
      "article-title": "Pharmaco\u2010dynamic profile of short\u2010term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GPIIb/IIIa receptor blockade",
      "volume": "97",
      "author": "Mascelli",
      "year": "1998",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0020",
      "doi-asserted-by": "crossref",
      "first-page": "1689",
      "DOI": "10.1056/NEJM199706123362401",
      "article-title": "Platelet glycoprotein IIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization",
      "volume": "336",
      "year": "1997",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0025",
      "doi-asserted-by": "crossref",
      "first-page": "1429",
      "DOI": "10.1016/S0140-6736(96)10452-9",
      "article-title": "Randomized placebo\u2010controlled trial of abciximab before and during coronary intervention in refractory unstable angina. The CAPTURE study",
      "volume": "349",
      "year": "1997",
      "journal-title": "Lancet"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0030",
      "doi-asserted-by": "crossref",
      "first-page": "319",
      "DOI": "10.1056/NEJM199907293410503",
      "article-title": "Complimentary clinical benefits of coronary\u2010artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors",
      "volume": "341",
      "author": "Lincoff",
      "year": "1999",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0035",
      "doi-asserted-by": "crossref",
      "first-page": "S33",
      "DOI": "10.1053/hj.1999.v138.99236",
      "article-title": "Readministration of abciximab: interim report of the ReoPro readministration registry",
      "volume": "138",
      "author": "Tcheng",
      "year": "1999",
      "journal-title": "Am Heart J"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0040",
      "doi-asserted-by": "crossref",
      "first-page": "311",
      "DOI": "10.1016/S0735-1097(98)00252-6",
      "article-title": "Occurrence and clinical significance of thrombocytopenia of a population of high\u2010risk percutaneous coronary revascularization",
      "volume": "32",
      "author": "Berkowitz",
      "year": "1998",
      "journal-title": "J Am Coll Cardiol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0045",
      "doi-asserted-by": "crossref",
      "first-page": "205",
      "DOI": "10.1002/(SICI)1096-8652(199907)61:3<205::AID-AJH8>3.0.CO;2-9",
      "article-title": "Acute profound thrombocytopenia following C7E3 Fab (abciximab) therapy: case reports, review of the literature, and implications for therapy",
      "volume": "61",
      "author": "Jubelirar",
      "year": "1999",
      "journal-title": "Am J Hematol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0050",
      "doi-asserted-by": "crossref",
      "first-page": "74",
      "DOI": "10.1067/mhj.2000.106615",
      "article-title": "Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade",
      "volume": "140",
      "author": "Kereiakes",
      "year": "2000",
      "journal-title": "Am Heart J"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0055",
      "doi-asserted-by": "crossref",
      "first-page": "S153",
      "DOI": "10.1016/S0002-8703(98)70243-1",
      "article-title": "Glycoprotein IIb/IIIa antagonists. Potential induction and detection of drug\u2010dependent antiplatelet antibodies",
      "volume": "135",
      "author": "Cines",
      "year": "1998",
      "journal-title": "Am Heart J"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0060",
      "doi-asserted-by": "crossref",
      "first-page": "435",
      "DOI": "10.1016/S0002-9149(99)00768-7",
      "article-title": "Effect of abciximab readministration in coronary intervention",
      "volume": "85",
      "author": "Madan",
      "year": "2000",
      "journal-title": "Am J Cardiol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0065",
      "doi-asserted-by": "crossref",
      "first-page": "3240",
      "DOI": "10.1182/blood.V92.9.3240",
      "article-title": "Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (\u03b1IIb/\u03b23) inhibitors",
      "volume": "92",
      "author": "Peter",
      "year": "1998",
      "journal-title": "Blood"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0070",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "DOI": "10.1016/S0002-9149(99)00370-7",
      "article-title": "Platelet activation as a potential mechanism of GPIIb/IIIa inhibitor\u2010induced thrombocytopenia",
      "volume": "84",
      "author": "Peter",
      "year": "1999",
      "journal-title": "Am J Cardiol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0075",
      "doi-asserted-by": "crossref",
      "first-page": "2054",
      "DOI": "10.1182/blood.V99.6.2054",
      "article-title": "Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab\u2010coated platelets",
      "volume": "99",
      "author": "Curtis",
      "year": "2002",
      "journal-title": "Blood"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0080",
      "doi-asserted-by": "crossref",
      "first-page": "1214",
      "DOI": "10.1161/01.CIR.97.12.1214",
      "article-title": "Delayed profound thrombocytopenia after c7E3 Fab (abciximab) therapy",
      "volume": "97",
      "author": "Jenkins",
      "year": "1998",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0085",
      "doi-asserted-by": "crossref",
      "first-page": "486",
      "DOI": "10.1002/ccd.1108",
      "article-title": "Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy",
      "volume": "52",
      "author": "Reddy",
      "year": "2001",
      "journal-title": "Cath Cardiovasc Interv"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0090",
      "doi-asserted-by": "crossref",
      "first-page": "151",
      "DOI": "10.1080/146288401753514515",
      "article-title": "Delayed thrombocytopenia following abciximab therapy",
      "volume": "4",
      "author": "Kaluski",
      "year": "2001",
      "journal-title": "J Cardiovasc Interv"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0095",
      "doi-asserted-by": "crossref",
      "first-page": "21",
      "DOI": "10.1177/107424840200700i103",
      "article-title": "Delayed profound thrombocytopenia presenting seven days after use of abciximab (ReoPro)",
      "volume": "7",
      "author": "Sharma",
      "year": "2002",
      "journal-title": "J Cardiovasc Pharmacol Therapeut"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0100",
      "doi-asserted-by": "crossref",
      "first-page": "418",
      "DOI": "10.1111/j.1365-2141.1994.tb04758.x",
      "article-title": "Incidence of autoantibodies to GPIIb/IIIa in chronic autoimmune thrombocytopenic purpura may be overestimated by the MAIPA",
      "volume": "86",
      "author": "Hewitt",
      "year": "1994",
      "journal-title": "Br J Haematol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0105",
      "doi-asserted-by": "crossref",
      "first-page": "596",
      "DOI": "10.1161/01.CIR.89.2.596",
      "article-title": "Randomized trial of GPIIb/IIIa platelet receptor blocker in refractory unstable angina",
      "volume": "89",
      "author": "Simoons",
      "year": "1994",
      "journal-title": "Circulation"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0110",
      "doi-asserted-by": "crossref",
      "first-page": "1271",
      "DOI": "10.1016/0161-5890(95)00085-2",
      "article-title": "The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions",
      "volume": "32",
      "author": "Knight",
      "year": "1995",
      "journal-title": "Mol Immunol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0115",
      "first-page": "2",
      "article-title": "Drug\u2010induced immune thrombocytopenia. An overview of pathogenesis",
      "volume": "36",
      "author": "Aster",
      "year": "1999",
      "journal-title": "Sem Hematol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0120",
      "series-title": "Platelets.",
      "first-page": "593",
      "article-title": "Drug\u2010induced thrombocytopenia",
      "author": "Aster",
      "year": "2002"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0125",
      "doi-asserted-by": "crossref",
      "first-page": "176",
      "DOI": "10.1182/blood.V84.1.176.176",
      "article-title": "Antibodies associated with sulfonamide\u2010induced immune thrombocytopenia react preferentially with calcium\u2010dependent epitopes on the glycoprotein IIb/IIIa complex",
      "volume": "84",
      "author": "Curtis",
      "year": "1994",
      "journal-title": "Blood"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0130",
      "doi-asserted-by": "crossref",
      "first-page": "1773",
      "DOI": "10.1056/NEJM200006153422402",
      "article-title": "Thrombotic thrombocytopenic purpura associated with clopidogrel",
      "volume": "342",
      "author": "Bennett",
      "year": "2000",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0135",
      "doi-asserted-by": "crossref",
      "first-page": "210",
      "DOI": "10.7326/0003-4819-136-3-200202050-00009",
      "article-title": "Delayed\u2010onset heparin\u2010induced thrombocytopenia",
      "volume": "136",
      "author": "Rice",
      "year": "2002",
      "journal-title": "Ann Intern Med"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0140",
      "doi-asserted-by": "crossref",
      "first-page": "1067",
      "DOI": "10.1056/NEJM200303133481120",
      "article-title": "Delayed onset heparin\u2010induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin",
      "volume": "348",
      "author": "Warkentin",
      "year": "2003",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0145",
      "doi-asserted-by": "crossref",
      "first-page": "81",
      "DOI": "10.1172/JCI116987",
      "article-title": "Antibodies from patients with heparin\u2010induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells",
      "volume": "93",
      "author": "Visentin",
      "year": "1994",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0150",
      "doi-asserted-by": "crossref",
      "first-page": "376",
      "DOI": "10.1016/S0022-2143(96)80009-6",
      "article-title": "Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: PF4 complexes",
      "volume": "128",
      "author": "Visentin",
      "year": "1996",
      "journal-title": "J Lab Clin Med"
    },
    {
      "issue": "Suppl. 1",
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0155",
      "doi-asserted-by": "crossref",
      "first-page": "S29",
      "DOI": "10.1023/A:1018708419564",
      "article-title": "Heparin\u2010induced thrombocytopenia and its treatment",
      "volume": "9",
      "author": "Warkentin",
      "year": "2000",
      "journal-title": "J Thromb Thrombolysis"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0160",
      "doi-asserted-by": "crossref",
      "first-page": "650",
      "DOI": "10.1111/j.1365-2141.1994.tb08333.x",
      "article-title": "A new type of pseudo\u2010thrombocytopenia: EDTA\u2010mediated agglutination of platelets bearing Fab fragments of a chimeric antibody",
      "volume": "87",
      "author": "Christopolous",
      "year": "1987",
      "journal-title": "Br J Haematol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0165",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "DOI": "10.1016/S0735-1097(00)00688-4",
      "article-title": "Occurrence and clinical significance of pseudo\u2010thrombocytopenia during abciximab therapy",
      "volume": "36",
      "author": "Sane",
      "year": "2000",
      "journal-title": "J Am Coll Cardiol"
    },
    {
      "issue": "Suppl. 1",
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0170",
      "first-page": "222a",
      "article-title": "Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetics: distinct binding profile for roxifiban and its implications",
      "volume": "94",
      "author": "Mousa",
      "year": "1999",
      "journal-title": "Blood"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0175",
      "doi-asserted-by": "crossref",
      "first-page": "729",
      "DOI": "10.1097/00001721-199304050-00009",
      "article-title": "Flow cytometric observations on thein vivouse of Fab fragments of a chimaeric monoclonal antibody to platelet glycoprotein IIb/IIIa",
      "volume": "4",
      "author": "Christopoulos",
      "year": "1993",
      "journal-title": "Blood Coag Fibrinol"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0180",
      "doi-asserted-by": "crossref",
      "first-page": "133",
      "DOI": "10.1159/000460705",
      "article-title": "Anti\u2010gamma globulin factors in human sera revealed by enzymatic splitting of anti\u2010Rh antibodies",
      "volume": "8",
      "author": "Osterland",
      "year": "1963",
      "journal-title": "Vox Sang"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0185",
      "doi-asserted-by": "crossref",
      "first-page": "723",
      "DOI": "10.1172/JCI112027",
      "article-title": "Anti\u2010Fab antibodies in humans: predominance of minor immunoglobulin G subclasses in rheumatoid arthritis",
      "volume": "76",
      "author": "Persselin",
      "year": "1985",
      "journal-title": "J Clin Invest"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0190",
      "first-page": "6851",
      "article-title": "Serological analysis of human anti\u2010human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33",
      "volume": "61",
      "author": "Ritter",
      "year": "2001",
      "journal-title": "Cancer Res"
    },
    {
      "key": "10.1111/j.1538-7836.2004.00744.x_bb0195",
      "doi-asserted-by": "crossref",
      "first-page": "6",
      "DOI": "10.1111/j.1365-2249.1994.tb06598.x",
      "article-title": "Platelet surface IgG in patients receiving infusions of Fab chimeric monoclonal antibody to glycoprotein IIb/IIIa",
      "volume": "98",
      "author": "Christopolous",
      "year": "1994",
      "journal-title": "Clin Exp Immunol"
    }
  ],
  "container-title": "Journal of Thrombosis and Haemostasis",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1538-7836.2004.00744.x",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1538783622158174?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1538783622158174?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2004.00744.x/fullpdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        1,
        16
      ]
    ],
    "date-time": "2023-01-16T04:43:30Z",
    "timestamp": 1673844210000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1538783622158174"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  },
  "references-count": 38,
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2004,
          6
        ]
      ]
    }
  },
  "alternative-id": [
    "S1538783622158174"
  ],
  "URL": "http://dx.doi.org/10.1111/j.1538-7836.2004.00744.x",
  "relation": {},
  "ISSN": [
    "1538-7836"
  ],
  "subject": [],
  "container-title-short": "Journal of Thrombosis and Haemostasis",
  "published": {
    "date-parts": [
      [
        2004,
        6
      ]
    ]
  },
  "assertion": [
    {
      "value": "Elsevier",
      "name": "publisher",
      "label": "This article is maintained by"
    },
    {
      "value": "Delayed thrombocytopenia after treatment with abciximab: a distinct clinical entity associated with the immune response to the drug",
      "name": "articletitle",
      "label": "Article Title"
    },
    {
      "value": "Journal of Thrombosis and Haemostasis",
      "name": "journaltitle",
      "label": "Journal Title"
    },
    {
      "value": "https://doi.org/10.1111/j.1538-7836.2004.00744.x",
      "name": "articlelink",
      "label": "CrossRef DOI link to publisher maintained version"
    },
    {
      "value": "article",
      "name": "content_type",
      "label": "Content Type"
    },
    {
      "value": "Copyright \u00a9 2004 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.",
      "name": "copyright",
      "label": "Copyright"
    }
  ]
}